Immune checkpoint inhibitors are advanced immuno oncology drugs that block inhibitory pathways used by cancer cells to evade immune system detection. These therapies target immune checkpoints such as CTLA 4, PD 1, and PD L1 to activate immune responses against tumors. Their effectiveness in improving survival rates across different cancer indications has significantly transformed modern...